Regulatory T Cells Move in When Gliomas Say "I DO"

被引：13
作者：
Choi, Bryan D. [1 ]
Fecci, Peter E. [2 ]
Sampson, John H. [1 ]
机构：
[1] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Duke Brain Tumor Immunotherapy Program, Div Neurosurg,Dept Surg,Med Ctr, Durham, NC 27710 USA
[2] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 22期
关键词：
BRAIN-TUMORS; CTLA-4; BLOCKADE; COMPARTMENT; SURVIVAL; IMMUNITY;
D O I：
10.1158/1078-0432.CCR-12-2801
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Indoleamine 2,3-dioxygenase (IDO) is an enzyme with known immunosuppressive and tolerogenic effects in cancer. Mounting evidence has associated IDO expression with the induction of regulatory T cells (Treg) and malignant progression. IDO inhibition may therefore provide a promising therapeutic approach for glioblastoma, where the need for novel treatment is great. Clin Cancer Res; 18(22); 6086-8. (C)2012 AACR.
引用
收藏
页码：6086 / 6088
页数：3
相关论文
共 12 条
[1]   Site-specific anti-tumor immunity: Differences in DC function, TGF-β production and numbers of intratumoral Foxp3+ Treg [J].
Biollaz, Gregoire ;
Bernasconi, Luca ;
Cretton, Christine ;
Puentener, Ursula ;
Frei, Karl ;
Fontana, Adriano ;
Suter, Tobias .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (05) :1323-1333
[2]   An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme [J].
El Andaloussi, Abdejabar ;
Lesniak, Maciej S. .
NEURO-ONCOLOGY, 2006, 8 (03) :234-243
[3]   Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors [J].
El Andaloussi, Abdeljabar ;
Lesniak, Maciej S. .
JOURNAL OF NEUROSURGERY, 2006, 105 (03) :430-437
[4]   Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. [J].
Fecci, PE ;
Mitchell, DA ;
Whitesides, JF ;
Xie, WH ;
Friedman, AH ;
Archer, GE ;
Herndon, JE ;
Bigner, DD ;
Dranoff, G ;
Sampson, JH .
CANCER RESEARCH, 2006, 66 (06) :3294-3302
[5]   Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function [J].
Fecci, Peter E. ;
Ochiai, Hidenobu ;
Mitchell, Duane A. ;
Grossi, Peter M. ;
Sweeney, Alison E. ;
Archer, Gary E. ;
Cummings, Thomas ;
Allison, James P. ;
Bigner, Darell D. ;
Sampson, John H. .
CLINICAL CANCER RESEARCH, 2007, 13 (07) :2158-2167
[6]   Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells [J].
Fecci, Peter E. ;
Sweeney, Alison E. ;
Grossi, Peter M. ;
Nair, Smita K. ;
Learn, Christopher A. ;
Mitchell, Duane A. ;
Cui, Xiuyu ;
Cummings, Thomas J. ;
Bigner, Darell D. ;
Gilboa, Eli ;
Sampson, John H. .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4294-4305
[7]   CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS [J].
Hodi, F. Stephen ;
Oble, Darryl A. ;
Drappatz, Jan ;
Velazquez, Elsa F. ;
Ramaiya, Nikhil ;
Ramakrishna, Naren ;
Day, Arthur L. ;
Kruse, Andrea ;
Mac Rae, Suzanne ;
Hoos, Axel ;
Mihm, Martin .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (09) :557-561
[8]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723
[9]   Immunotherapy of malignant brain tumors [J].
Mitchell, Duane A. ;
Fecci, Peter E. ;
Sampson, John H. .
IMMUNOLOGICAL REVIEWS, 2008, 222 :70-100
[10]   Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans [J].
Mitchell, Duane A. ;
Cui, Xiuyu ;
Schmittling, Robert J. ;
Sanchez-Perez, Luis ;
Snyder, David J. ;
Congdon, Kendra L. ;
Archer, Gary E. ;
Desjardins, Annick ;
Friedman, Allan H. ;
Friedman, Henry S. ;
Herndon, James E., II ;
McLendon, Roger E. ;
Reardon, David A. ;
Vredenburgh, James J. ;
Bigner, Darell D. ;
Sampson, John H. .
BLOOD, 2011, 118 (11) :3003-3012
12